Objectives of the meeting
This aim of the meeting is to review current evidence regarding correlates of protection against COVID-19, identify gaps in knowledge and define research strategies to advance vaccine-induced protection against beta coronaviruses. The meeting will also discuss the role of controlled human infection model studies for the identification of correlates of protection and evaluation of novel vaccines.
A multidisciplinary panel of experts will participate in the meeting. Ample time will be given to discussions to generate a common understanding of the topic and define guidelines for the way forward. Proceedings and conclusions from the conference will be published in Biologicals.
Scientific Committee
- Cristina Cassetti National Institute of Allergy and Infectious Diseases, NIH
- Jakob Cramer Coalition for Epidemic Preparedness Innovations (CEPI)
- Marion Gruber International AIDS Vaccine Initiative (IAVI)
- Adam Hacker Coalition for Epidemic Preparedness Innovations (CEPI)
- Deborah King Wellcome Trust
- Arnaud Marchant Université Libre de Belgique
- Pieter Neels International Alliance for Biological Standardization (IABS)
- Stanley Plotkin Vaxconsult, LLC
- Pierre Van Damme University of Antwerp
- Joris Vandeputte International Alliance for Biological Standardization (IABS)
Organising Committee
- Abbie Charlet, IABS, France
- Madinina Cox, MC’Com, France